Chapter 5 – Euro-PCT procedure before the EPO as a designated or elected Office
  1. Home
  2. Legal texts
  3. Euro-PCT Guide
  4. Contents
  5. Chapter 5
  6. 5.6 Biological material and nucleotide and amino acid sequences
  7. Waiver under Rule 33(2) EPC
Print
Facebook Twitter Linkedin Email

5.6 Biological material and nucleotide and amino acid sequences

Overview

5.6.2.Waiver under Rule 33(2) EPC 

5.6.004The issue of a sample of biological material may be requested by any person under the conditions set out in Rule 33(1) EPC. Rule 33(2) EPC requires that the requester has undertaken vis-à-vis the applicant not to make the biological material, or any biological material derived therefrom, available to any third party and to use that material for experimental purposes only, until such time as the European patent application is refused or withdrawn or deemed to be withdrawn, or before the European patent has expired in all the designated states.

OJ 2010, 498

5.6.005In Form 1200, Section 8, applicants are given the option of waiving their right to an undertaking by the requester pursuant to Rule 33(2) EPC on condition that they are the depositor of the biological material. The waiver must be submitted in a separate letter in the form of a signed statement containing a specification of the biological material concerned. Such waiver may be filed at any time during the proceedings before the EPO.

Previous
Next
Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility